Medium-term multi-organ carcinogenesis bioassay of ethyl tertiary-butyl ether in rats

Toxicology

Volumn 289, Issue 2-3, 2011, Pages 160-166

  Hagiwara, Akihiro ^a   Doi, Yuko ^a   Imai, Norio ^a   Nakashima, Hironao ^a   Ono, Takahiro ^a   Kawabe, Mayumi ^a   Furukawa, Fumio ^a   Tamano, Seiko ^a   Nagano, Kasuke ^b   Fukushima, Shoji ^b  

^a Daiyukai Research Institute for Medical Science   (Japan)

^b JAPAN INDUSTRIAL SAFETY AND HEALTH ASSOCIATION   (Japan)

Author keywords

Carcinogenesis bioassay; Ethyl tertiary butyl ether; F344 rats; Medium term; Multi organ

Indexed keywords

ETHER DERIVATIVE; ETHYL TERT BUTYL ETHER; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLADDER PAPILLOMA; CARCINOGENESIS; CELL HYPERPLASIA; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FORESTOMACH; HYPERPLASIA; KIDNEY TUBULE; LIVER ADENOMA; MALE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RAT; SQUAMOUS CELL; THYROID FOLLICLE CELL; THYROID TUMOR;

ADENOCARCINOMA; ADENOMA, LIVER CELL; ANIMALS; CARCINOGENS; COCARCINOGENESIS; COLONIC NEOPLASMS; ETHYL ETHERS; KIDNEY NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; THYROID NEOPLASMS;

ANIMALIA; RATTUS;

EID: 80052707209     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.08.007     Document Type: Article

References (40)

1. American Cancer Society, 2011. MTBE. Available from (accessed on July 25). http://www.cancer.org/cancer/cancercauses/othercarcinogens/pollution/mtbe.
2. Belpoggi F., Soffritti M., Filippini F., Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether. Ann. N.Y. Acad. Sci. 1997, 837:77-95.
3. Bird M.G., Burleigh-Flayer H.D., Chun J.S., Douglas J.F., Kneiss J.J., Andrews L.S. Oncogenicity studies of inhaled methyl tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats. J. Appl. Toxicol. 1997, 1(Suppl. 1):S45-S55.
4. Borghoff S.J., Prescott J.S., Janszen D.B., Wong B.A., Everitt J.I. α2u-globulin nephropathy, renal cell proliferation, and dosimetry of inhaled tert-butyl alcohol in male and female F-344 rats. Toxicol. Sci. 2001, 61:176-186.
5. Cirvello J.D., Radovsky A., Heath J.E., Farnell D.R., Lindamood C. Toxicity and carcinogenicity of t-butyl alcohol in rats and mice following chronic exposure in drinking water. Toxicol. Ind. Health 1995, 11:151-165.
6. Cohen S.M. Role of urinary physiology and chemistry in bladder carcinogenesis. Food Chem. Toxicol. 1995, 33:715-730.
7. Cohen S.M., Ohnishi T., Clark N.M., He J., Arnold L.L. Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol. Pathol. 2007, 35:337-347.
8. Davis J.M., Farland W.H. The paradoxes of MTBE. Toxicol. Sci. 2001, 61:211-217.
9. Fukushima S., Murai T. Calculi precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis 1999, 159-174. IARC Scientifc Publications No. 147, Lyon. C.C. Capen, E. Dybing, J.M. Rice, J.D. Wilbourn (Eds.).
10. Hard G.C. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ. Health Perspect. 1998, 106:427-436.
11. Hasegawa R., Tanaka H., Tamano S., Shirai T., Nagao M., Sugimura T., Ito N. Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay. Carcinogenesis 1994, 15:2567-2573.
12. Hill R.N., Erdreich L.S., Paynter O.E., Roberts P.A., Rosenthal S.L., Wilkinson C.F. Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 1989, 12:629-697.
13. Ito N., Hasegawa R., Imaida K., Hirose M., Shirai T. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp. Toxicol. Pathol. 1996, 48:113-119.
14. Ito N., Hirose M., Takahashi S. Cell proliferation and forestomach carcinogenesis. Environ. Health Perspect. 1993, 101:107-110.
15. Ito N., Imaida K., Asamoto M., Shirai T. Early detection of carcinogenic substances and modifiers in rats. Mutat. Res. 2000, 462:209-217.
16. Kroes R., Wester P.W. Forestomach carcinogens: possible mechanisms of action. Food Chem. Toxicol. 1986, 24:1083-1089.
17. Maltoni C., Belpoggi F., Soffritti M., Minardi F. Comprehensive long-term experimental project of carcinogenicity bioassays on gasoline oxygenated additives: plan and first report of results from the study on ethyl-tertiary-butyl ether (ETBE). Eur. J. Oncol. 1999, 4:493-508.
18. Masui T., Garland E.M., Wang C.Y., Cohen S.M. Effects of different types of diet and sodium saccharin on proliferation at the limiting ridge of the rat forestomach. Food Chem. Toxicol. 1990, 28:497-505.
19. McCarthy, J.E., Tiemann, M., 2006. MTBE in gasoline: clean air and drinking water issues. Congressional Research Service Reports, Paper 26, University of Nebraska. Available from (accessed 25.07.11). http://digitalcommons.unl.edu/crsdocs/26.
20. McClain R.M., Levin A.A., Posch R., Downing J.C. The effect of phenobarbital on the metabolism and excrtion of thyroxine in rats. Toxicol. Appl. Pharmacol. 1989, 99:216-228.
21. McClain R.M., Posch R.C., Bosakowski T., Armstrong J.M. Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital. Toxicol. Appl. Pharmacol. 1988, 94:254-265.
22. McGregor D. Methyl tertiary-butyl ether: studies for potential human health hazards. Crit. Rev. Toxicol. 2006, 36:319-358.
23. McGregor D. Ethyl tertiary-butyl ether: a toxicological review. Crit. Rev. Toxicol. 2007, 37:287-312.
24. Medinsky M.A., Wolf D.C., Cattley R.C., Wong B., Janszen D.B., Farris G.M., Wright G.A., Bond J.A. Effect of a thirteen-week inhalation exposure to ethyl tertiary butyl ether on Fischer-344 rats and CD-1 mice. Toxicol. Sci. 1999, 51:108-118.
25. Mennear J.H. Carcinogenicity studies on MTBE: critical review and interpretation. Risk Anal. 1997, 17:673-681.
26. Moser G.J., Wong B.A., Wolf D.C., Fransson-Steen R.L., Goldworthy T.L. Methyl tertiary butyl ether lacks tumor-promoting activity in N-nitrosodiethylamine-initiated B6C3F1 female mouse liver. Carcinogenesis 1996, 17:2753-2761.
27. Moser G.J., Wong B.A., Wolf D.C., Moss O.R., Goldworthy T.L. Comparative short-term effects of methyl tertiary butyl ether and unleaded gasoline vapor in female B6C3F1 mice. Fundam. Appl. Toxicol. 1996, 31:173-183.
28. Nagano K., Nishizawa T., Yamazaki K., Noguchi T., Hagiwara A., Nishimaki F., Iida S., Komiya K., Fukushima S. Hepatotumorigenicity of ethyl tertiary-butyl ether (ETBE) by inhalation exposure but not oral administration in F344 rats. The Toxicologist (Washington, DC) 2011.
29. NTP, 1995. Toxicology and carcinogenesis studies of t-butyl alcohol in F344/N rats and B6C3F1 mice (Tech. Rep. Ser. No.436; NIH Publ. No. 95-3167). National Toxicology Program, Research Triangle Park, NC.
30. Okumura M., Hasegawa R., Shirai T., Ito M., Yamada S., Fukushima S. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxic agents thymine or melamine. Carcinogenesis 1992, 13:1043-1045.
31. Otoshi T., Iwata H., Kitano M., Nishizawa Y., Morii H., Yano Y., Otani S., Fukushima S. Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1α,25-dihydroxyvitamin D3. Carcinogenesis 1995, 16:2091-2097.
32. Paynter O.E., Burin G.J., Jaeger R.B., Gregorio C.A. Goitrogens and thyroid follicular cell neoplasia: evidence for a threshold process. Regul. Toxicol. Pharmacol. 1988, 8:102-119.
33. Poet T.S., Borghoff S.J. In vitro uptake of methyl tert-butyl ether in male rat kidney: use of a two-compartment model to describe protein interactions. Toxicol. Appl. Pharmacol. 1997, 145:340-348.
34. Proctor D.M., Gatto N.M., Hong S.J., Allamneni K.P. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment. Toxicol. Sci. 2007, 98:313-326.
35. Shirai T., Fukushima S., Tagawa Y., Okumura M., Ito N. Cell proliferation induced by uracil-calculi and subsequent development of reversible papillomatosis in the rat urinary bladder. Cancer Res. 1989, 49:378-383.
36. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals. The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation 1999, 251-272. IARC Scientifc Publications No. 146, Lyon. T. Shirai, M. Hirose, N. Ito, D.B. McGregor, J.M. Rice, S. Venitt (Eds.).
37. Takahashi S., Hakoi K., Yada H., Hirose M., Ito N., Fukushima S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis 1992, 13:1513-1518.
38. Tsuda H., Futakuchi M., Fukamachi K., Shirai T., Imaida K., Fukushima S., Tatematsu M., Furukawa F., Tamano S., Ito N. A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol. Pathol. 2010, 38:182-187.
39. Whysner J., Williams G.M. Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 1996, 71:137-151.
40. Williams T.M., Borghoff S.J. Characterization of tert-butyl alcohol binding to alpha2u-globulin in F344 rats. Toxicol. Sci. 2001, 62:228-235.